; (B) services, programs, or strategies to prevent substance use disorder, including evidence-based education campaigns, community-based prevention programs, opioid diversion, collection and disposal of unused prescription drugs, and services to at-risk populations to prevent or delay initial use of an illicit substance; (C) substance use disorder treatment; (D) illicit drug use research; (E) drug-free workplace programs; (F) drug testing, including the testing of employees; (G) interventions for illicit drug use and dependence; (H) expanding availability of access to health care services for the treatment of substance use disorders; (I) international drug control coordination and cooperation with respect to activities described in this paragraph; (J) pre- and post-arrest criminal justice interventions such as diversion programs, drug courts, and the provision of evidence-based treatment to individuals with substance use disorders who are arrested or under some form of criminal justice supervision, including medication assisted treatment; (K) other coordinated and joint initiatives among Federal, State, local, and Tribal agencies to promote comprehensive drug control strategies designed to reduce the demand for, and the availability of, illegal drugs; (L) international illicit drug use education, prevention, treatment, recovery, research, rehabilitation activities, and interventions for illicit drug use and dependence; and (M) research related to any of the activities described in this paragraph. (3) Director The term Director means the Director of the Office of National Drug Control Policy. (4) Drug control The term drug control means any activity conducted by a National Drug Control Program Agency involving supply reduction or demand reduction. (5) Illicit drug use; illicit drugs